Researchers from the Children’s Hospital of Philadelphia (CHOP) have developed a noninvasive magnetic resonance imaging (MRI) technique for studying adult zebrafish, providing valuable insights into genetic mutations associated with mitochondrial disease. This research, published Zebrafish, is expected to advance the study of complex genetic diseases.

Zebrafish are renowned for their utility in studying rare genetic diseases due to their rapid development and transparent bodies, which facilitate microscopic imaging of organs and time-lapse disease progression analyses. Additionally, zebrafish can absorb drugs through their skin, gut, or thin gills, making them valuable in drug screening for various illnesses.

Search Antibodies
Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.

However, as zebrafish age, their denser tissues and less accessible organs pose challenges for conventional microscopic imaging. Previous MRI studies on zebrafish were limited and lacked systematic organ-level analyses, which are crucial for diseases like mitochondrial disease affecting multiple organs.

This CHOP study introduces a novel MRI protocol tailored to zebrafish research, enabling high-resolution MRI of eight different organs in adult zebrafish. Researchers created a reference MRI atlas for zebrafish aged five to 31 months after fertilization.

Utilizing this technique, the team investigated three mitochondrial disease mutant zebrafish models and made significant observations. Zebrafish with a deficiency in the SURF1 gene, associated with Leigh syndrome, exhibited markedly increased brain growth. Conversely, heart and spinal cord volumes were reduced in these mutants compared to healthy counterparts, mirroring clinical observations in humans with SURF1 deficiency, who often suffer from neurological issues and cardiomyopathy.

"This work demonstrated that MRI allows us to rapidly and comprehensively study organ-level growth defects in mutant adult zebrafish in a low-cost, minimally invasive, and unbiased manner," explained Sonal Sharma, the study's lead author.